CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
Go back to CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference| (NASDAQ: CRVO) | Delayed: 2.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.86 | 52 Week High | $ | |||
| Open | $2.86 | 52 Week Low | $ | |||
| Day High | $2.86 | P/E | N/A | |||
| Day Low | $2.86 | EPS | $ | |||
| Volume | 5,662 | |||||
